Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus

This publication has 30 references indexed in Scilit:

• Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan
  Bone Marrow Transplantation, 2001
• Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines
  Gene Therapy, 2000
• Clinical Protocol: A Phase I-II Trial to Examine the Toxicity of CMV- and EBV-Specific Cytotoxic T Lymphocytes When Used for Prophylaxis against EBV and CMV Disease in Recipients of CD34-Selected/T Cell-Depleted Stem Cell Transplants
  Human Gene Therapy, 2000
• CHARACTERIZATION OF CMVpp65-SPECIFIC CD8+ T LYMPHOCYTES USING MHC TETRAMERS IN KIDNEY TRANSPLANT PATIENTS AND HEALTHY PARTICIPANTS1
  Transplantation, 2000
• HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION
  Annual Review of Immunology, 1997
• The N-terminal 303 amino acids of the human cytomegalovirus envelope glycoprotein B (UL55) and the exon 4 region of the major immediate early protein 1 (UL123) induce a cytotoxic T-cell response
  Vaccine, 1996
• Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3
  Journal of General Virology, 1994
• Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8⁺ virus‐specific cytotoxic T lymphocytes
  Journal of Medical Virology, 1994
• Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
  Science, 1992
• Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow Transplantation
  New England Journal of Medicine, 1986